A Rising Drug Burden Index Is Related With Malnutrition in Community-Dwelling Older Adults With Dementia.

IF 1.5 4区 医学 Q4 CLINICAL NEUROLOGY Clinical Neuropharmacology Pub Date : 2025-05-01 Epub Date: 2025-03-07 DOI:10.1097/WNF.0000000000000629
Sultan Keskin Demircan, Mehmet Ilkin Naharci
{"title":"A Rising Drug Burden Index Is Related With Malnutrition in Community-Dwelling Older Adults With Dementia.","authors":"Sultan Keskin Demircan, Mehmet Ilkin Naharci","doi":"10.1097/WNF.0000000000000629","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Malnutrition is common in dementia patients and can lead to poor outcomes. Also, these patients are often prescribed medications with sedative and anticholinergic effects for various reasons. Thus, we aimed to explore the relationship between drug burden index (DBI), anticholinergic burden (ACB), and nutrition status in community-dwelling older adults with dementia.</p><p><strong>Method: </strong>A total of 415 outpatients with dementia, evaluated by Mini Nutrition Assessment, and whose drug information is registered are included in study. DBI score was calculated by summing the scores of regularly used anticholinergic and/or sedative drugs taken for at least four weeks prior to admission.</p><p><strong>Results: </strong>The mean age of participants was 77.4 ± 6.3 years, and the majority were female (64.3%). The most prevalent type of dementia (71.6%) was Alzheimer's dementia. The prevalence of malnutrition is 23.6%. Polypharmacy was present in approximately half of the participants (47.5). In total, 57.0% of the participants were using anticholinergic drugs, and 77% of the participants had drug exposure. In the fully adjusted multivariate models, an increase in DBI score raised the risk of \"malnutrition\" by 2.12 times (OR, 2.12; 95% CI, 1.15-4.01; P = 0.02), whereas no relationship was determined between ACB score and \"malnutrition\" (OR, 1.21; 95% CI, 0.98-1.49; P = 0.07).</p><p><strong>Conclusions: </strong>Older adults with dementia are frequently exposed to drugs with sedative and anticholinergic properties. Considering the relationship between DBI and malnutrition, these drugs and doses should be optimized to prevent malnutrition and its adverse outcomes in this vulnerable population.</p>","PeriodicalId":10449,"journal":{"name":"Clinical Neuropharmacology","volume":" ","pages":"73-78"},"PeriodicalIF":1.5000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNF.0000000000000629","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/7 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Malnutrition is common in dementia patients and can lead to poor outcomes. Also, these patients are often prescribed medications with sedative and anticholinergic effects for various reasons. Thus, we aimed to explore the relationship between drug burden index (DBI), anticholinergic burden (ACB), and nutrition status in community-dwelling older adults with dementia.

Method: A total of 415 outpatients with dementia, evaluated by Mini Nutrition Assessment, and whose drug information is registered are included in study. DBI score was calculated by summing the scores of regularly used anticholinergic and/or sedative drugs taken for at least four weeks prior to admission.

Results: The mean age of participants was 77.4 ± 6.3 years, and the majority were female (64.3%). The most prevalent type of dementia (71.6%) was Alzheimer's dementia. The prevalence of malnutrition is 23.6%. Polypharmacy was present in approximately half of the participants (47.5). In total, 57.0% of the participants were using anticholinergic drugs, and 77% of the participants had drug exposure. In the fully adjusted multivariate models, an increase in DBI score raised the risk of "malnutrition" by 2.12 times (OR, 2.12; 95% CI, 1.15-4.01; P = 0.02), whereas no relationship was determined between ACB score and "malnutrition" (OR, 1.21; 95% CI, 0.98-1.49; P = 0.07).

Conclusions: Older adults with dementia are frequently exposed to drugs with sedative and anticholinergic properties. Considering the relationship between DBI and malnutrition, these drugs and doses should be optimized to prevent malnutrition and its adverse outcomes in this vulnerable population.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
社区居住老年痴呆患者药物负担指数上升与营养不良相关
目的:营养不良在痴呆症患者中很常见,并可能导致不良预后。此外,由于各种原因,这些患者经常被开有镇静和抗胆碱能作用的药物。因此,我们旨在探讨社区居住老年痴呆患者的药物负担指数(DBI)、抗胆碱能负担(ACB)和营养状况之间的关系。方法:选取415例经Mini营养评估并注册药物信息的痴呆门诊患者作为研究对象。DBI评分是通过将入院前至少四周定期服用的抗胆碱能药物和/或镇静药物的评分相加来计算的。结果:参与者平均年龄77.4±6.3岁,以女性居多(64.3%)。最常见的痴呆类型是阿尔茨海默氏痴呆(71.6%)。营养不良发生率为23.6%。大约一半的参与者(47.5)存在多重用药。总的来说,57.0%的参与者正在使用抗胆碱能药物,77%的参与者有药物暴露。在完全调整的多变量模型中,DBI评分的增加使“营养不良”的风险增加了2.12倍(OR, 2.12;95% ci, 1.15-4.01;P = 0.02),而ACB评分与“营养不良”之间没有关系(OR, 1.21;95% ci, 0.98-1.49;P = 0.07)。结论:老年痴呆患者经常暴露于具有镇静和抗胆碱能特性的药物。考虑到DBI与营养不良之间的关系,应优化这些药物和剂量,以预防这一弱势群体的营养不良及其不良后果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Neuropharmacology
Clinical Neuropharmacology 医学-临床神经学
CiteScore
1.20
自引率
10.00%
发文量
63
审稿时长
6-12 weeks
期刊介绍: Clinical Neuropharmacology is a peer-reviewed journal devoted to the pharmacology of the nervous system in its broadest sense. Coverage ranges from such basic aspects as mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptoms. The journal publishes original articles and brief reports, invited and submitted reviews, and letters to the editor. A regular feature is the Patient Management Series: in-depth case presentations with clinical questions and answers.
期刊最新文献
Risk Factors for Symptom Aggravation in Acute Ischemic Stroke Due to Anterior Circulation Large Vessel Occlusion. Efficacy and Tolerability of Cenobamate in Treating Refractory Focal Epilepsy: Results From the 6-month Open-label Cenobamate in Focal Epilepsy Study (CIFES). The Principal Component of the Inflammatory Biomarkers is the Best Predictor of Neuropsychiatric Disorders in Long COVID Patients. Efficacy and Safety of Deferiprone for Parkinson's Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Electroconvulsive Therapy for Refractory Anxiety and Depression in Superficial Siderosis: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1